Cargando…

Multimodal Imaging Techniques Show Differences in Homing Capacity Between Mesenchymal Stromal Cells and Macrophages in Mouse Renal Injury Models

PURPOSE: The question of whether mesenchymal stromal cells (MSCs) home to injured kidneys remains a contested issue. To try and understand the basis for contradictory findings reported in the literature, our purpose here was to investigate whether MSC homing capacity is influenced by administration...

Descripción completa

Detalles Bibliográficos
Autores principales: Taylor, Arthur, Sharkey, Jack, Harwood, Rachel, Scarfe, Lauren, Barrow, Michael, Rosseinsky, Matthew J., Adams, Dave J., Wilm, Bettina, Murray, Patricia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343735/
https://www.ncbi.nlm.nih.gov/pubmed/31823201
http://dx.doi.org/10.1007/s11307-019-01458-8
_version_ 1783555809820540928
author Taylor, Arthur
Sharkey, Jack
Harwood, Rachel
Scarfe, Lauren
Barrow, Michael
Rosseinsky, Matthew J.
Adams, Dave J.
Wilm, Bettina
Murray, Patricia
author_facet Taylor, Arthur
Sharkey, Jack
Harwood, Rachel
Scarfe, Lauren
Barrow, Michael
Rosseinsky, Matthew J.
Adams, Dave J.
Wilm, Bettina
Murray, Patricia
author_sort Taylor, Arthur
collection PubMed
description PURPOSE: The question of whether mesenchymal stromal cells (MSCs) home to injured kidneys remains a contested issue. To try and understand the basis for contradictory findings reported in the literature, our purpose here was to investigate whether MSC homing capacity is influenced by administration route, the type of injury model used, and/or the presence of exogenous macrophages. PROCEDURES: To assess the viability, whole-body biodistribution, and intra-renal biodistribution of MSCs, we used a multimodal imaging strategy comprising bioluminescence and magnetic resonance imaging. The effect of administration route (venous or arterial) on the ability of MSCs to home to injured renal tissue, and persist there, was assessed in a glomerular injury model (induced by the nephrotoxicant, Adriamycin) and a tubular injury model induced by ischaemia-reperfusion injury (IRI). Exogenous macrophages were used as a positive control because these cells are known to home to injured mouse kidneys. To assess whether the homing capacity of MSCs can be influenced by the presence of exogenous macrophages, we used a dual-bioluminescence strategy that allowed the whole-body biodistribution of the two cell types to be monitored simultaneously in individual animals. RESULTS: Following intravenous administration, no MSCs were detected in the kidneys, irrespective of whether the mice had been subjected to renal injury. After arterial administration via the left cardiac ventricle, MSCs transiently populated the kidneys, but no preferential homing or persistence was observed in injured renal tissue after unilateral IRI. An exception was when MSCs were co-administered with exogenous macrophages; here, we observed some homing of MSCs to the injured kidney. CONCLUSIONS: Our findings strongly suggest that MSCs do not home to injured kidneys. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s11307-019-01458-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7343735
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-73437352020-07-13 Multimodal Imaging Techniques Show Differences in Homing Capacity Between Mesenchymal Stromal Cells and Macrophages in Mouse Renal Injury Models Taylor, Arthur Sharkey, Jack Harwood, Rachel Scarfe, Lauren Barrow, Michael Rosseinsky, Matthew J. Adams, Dave J. Wilm, Bettina Murray, Patricia Mol Imaging Biol Research Article PURPOSE: The question of whether mesenchymal stromal cells (MSCs) home to injured kidneys remains a contested issue. To try and understand the basis for contradictory findings reported in the literature, our purpose here was to investigate whether MSC homing capacity is influenced by administration route, the type of injury model used, and/or the presence of exogenous macrophages. PROCEDURES: To assess the viability, whole-body biodistribution, and intra-renal biodistribution of MSCs, we used a multimodal imaging strategy comprising bioluminescence and magnetic resonance imaging. The effect of administration route (venous or arterial) on the ability of MSCs to home to injured renal tissue, and persist there, was assessed in a glomerular injury model (induced by the nephrotoxicant, Adriamycin) and a tubular injury model induced by ischaemia-reperfusion injury (IRI). Exogenous macrophages were used as a positive control because these cells are known to home to injured mouse kidneys. To assess whether the homing capacity of MSCs can be influenced by the presence of exogenous macrophages, we used a dual-bioluminescence strategy that allowed the whole-body biodistribution of the two cell types to be monitored simultaneously in individual animals. RESULTS: Following intravenous administration, no MSCs were detected in the kidneys, irrespective of whether the mice had been subjected to renal injury. After arterial administration via the left cardiac ventricle, MSCs transiently populated the kidneys, but no preferential homing or persistence was observed in injured renal tissue after unilateral IRI. An exception was when MSCs were co-administered with exogenous macrophages; here, we observed some homing of MSCs to the injured kidney. CONCLUSIONS: Our findings strongly suggest that MSCs do not home to injured kidneys. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s11307-019-01458-8) contains supplementary material, which is available to authorized users. Springer International Publishing 2019-12-10 2020 /pmc/articles/PMC7343735/ /pubmed/31823201 http://dx.doi.org/10.1007/s11307-019-01458-8 Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Research Article
Taylor, Arthur
Sharkey, Jack
Harwood, Rachel
Scarfe, Lauren
Barrow, Michael
Rosseinsky, Matthew J.
Adams, Dave J.
Wilm, Bettina
Murray, Patricia
Multimodal Imaging Techniques Show Differences in Homing Capacity Between Mesenchymal Stromal Cells and Macrophages in Mouse Renal Injury Models
title Multimodal Imaging Techniques Show Differences in Homing Capacity Between Mesenchymal Stromal Cells and Macrophages in Mouse Renal Injury Models
title_full Multimodal Imaging Techniques Show Differences in Homing Capacity Between Mesenchymal Stromal Cells and Macrophages in Mouse Renal Injury Models
title_fullStr Multimodal Imaging Techniques Show Differences in Homing Capacity Between Mesenchymal Stromal Cells and Macrophages in Mouse Renal Injury Models
title_full_unstemmed Multimodal Imaging Techniques Show Differences in Homing Capacity Between Mesenchymal Stromal Cells and Macrophages in Mouse Renal Injury Models
title_short Multimodal Imaging Techniques Show Differences in Homing Capacity Between Mesenchymal Stromal Cells and Macrophages in Mouse Renal Injury Models
title_sort multimodal imaging techniques show differences in homing capacity between mesenchymal stromal cells and macrophages in mouse renal injury models
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343735/
https://www.ncbi.nlm.nih.gov/pubmed/31823201
http://dx.doi.org/10.1007/s11307-019-01458-8
work_keys_str_mv AT taylorarthur multimodalimagingtechniquesshowdifferencesinhomingcapacitybetweenmesenchymalstromalcellsandmacrophagesinmouserenalinjurymodels
AT sharkeyjack multimodalimagingtechniquesshowdifferencesinhomingcapacitybetweenmesenchymalstromalcellsandmacrophagesinmouserenalinjurymodels
AT harwoodrachel multimodalimagingtechniquesshowdifferencesinhomingcapacitybetweenmesenchymalstromalcellsandmacrophagesinmouserenalinjurymodels
AT scarfelauren multimodalimagingtechniquesshowdifferencesinhomingcapacitybetweenmesenchymalstromalcellsandmacrophagesinmouserenalinjurymodels
AT barrowmichael multimodalimagingtechniquesshowdifferencesinhomingcapacitybetweenmesenchymalstromalcellsandmacrophagesinmouserenalinjurymodels
AT rosseinskymatthewj multimodalimagingtechniquesshowdifferencesinhomingcapacitybetweenmesenchymalstromalcellsandmacrophagesinmouserenalinjurymodels
AT adamsdavej multimodalimagingtechniquesshowdifferencesinhomingcapacitybetweenmesenchymalstromalcellsandmacrophagesinmouserenalinjurymodels
AT wilmbettina multimodalimagingtechniquesshowdifferencesinhomingcapacitybetweenmesenchymalstromalcellsandmacrophagesinmouserenalinjurymodels
AT murraypatricia multimodalimagingtechniquesshowdifferencesinhomingcapacitybetweenmesenchymalstromalcellsandmacrophagesinmouserenalinjurymodels